Oragenics Inc Share Price Nyse
Equities
US6840232036
Biotechnology & Medical Research
Sales 2022 | 0.13 10.98 | Sales 2023 | 0.04 3.14 | Capitalization | 1.45Cr 120.68Cr |
---|---|---|---|---|---|
Net income 2022 | -1.4Cr -116.87Cr | Net income 2023 | -2Cr -166.96Cr | EV / Sales 2022 | 1,18,42,208 x |
Net cash position 2022 | 1.08Cr 90Cr | Net cash position 2023 | 31.61L 26Cr | EV / Sales 2023 | 29,99,79,895 x |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.61
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.77% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 28/12 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 07/23/07 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 04/10/04 |
John Gandolfo
BRD | Director/Board Member | 63 | 04/23/04 |
Robert Koski
BRD | Director/Board Member | 65 | 30/09/30 |
1st Jan change | Capi. | |
---|---|---|
+15.55% | 12TCr | |
+12.66% | 11TCr | |
-2.53% | 2.48TCr | |
+0.70% | 2.25TCr | |
-9.65% | 1.83TCr | |
-42.28% | 1.63TCr | |
-18.92% | 1.53TCr | |
+6.19% | 1.41TCr | |
+28.83% | 1.17TCr |